TY  - JOUR
AU  - Flores, M Luz
AU  - Castilla, Carolina
AU  - Gasca, Jessica
AU  - Medina, Rafael
AU  - Pérez-Valderrama, Begoña
AU  - Romero, Francisco
AU  - Japón, Miguel A
AU  - Sáez, Carmen
PY  - 2016
DO  - 10.1158/1535-7163.MCT-15-0951
UR  - http://hdl.handle.net/10668/10102
T2  - Molecular cancer therapeutics
AB  - Prostate cancer is the leading cause of cancer-related death among men in developed countries. Although castration therapy is initially effective, prostate cancers progress to hormone-refractory disease and in this case taxane-based chemotherapy is...
LA  - en
KW  - Antineoplastic Agents, Phytogenic
KW  - Apoptosis
KW  - Aurora Kinase A
KW  - Cell Cycle Checkpoints
KW  - Cell Line, Tumor
KW  - Chromones
KW  - Drug Resistance, Neoplasm
KW  - Gene Expression
KW  - Gene Silencing
KW  - Humans
KW  - Male
KW  - Mitosis
KW  - Models, Biological
KW  - Morpholines
KW  - Myeloid Cell Leukemia Sequence 1 Protein
KW  - Paclitaxel
KW  - Prostatic Neoplasms
KW  - Protein Kinase C-delta
KW  - Proto-Oncogene Proteins c-akt
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Wnt Signaling Pathway
KW  - beta Catenin
TI  - Loss of PKCδ Induces Prostate Cancer Resistance to Paclitaxel through Activation of Wnt/β-Catenin Pathway and Mcl-1 Accumulation.
TY  - research article
VL  - 15
ER  -